Medscape1d
Neuropathic Arthropathy of the Shoulder (Charcot Shoulder)
Although Charcot initially described the sequelae ... Additionally, disruption of the sympathetic pathways may result in a Horner's syndrome or vasomotor and trophic changes, again most common ...
Hosted on MSN11d
FDA grants ODD to NMD Pharma’s Charcot-Marie-Tooth disease therapy
The US Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to NMD Pharma’s oral lead development ...
NMD Pharma Announces FDA Orphan Drug Designation Granted to NMD670 for the Treatment of Patients with Charcot-Marie-Tooth Disease
NMD Pharma Announces FDA Orphan Drug Designation Granted to NMD670 for the Treatment of Patients with Charcot-Marie-Tooth Disease This is the 2nd ...
pharmaphorum1d
Pharnext hit again as rare disease drug flunks phase 3 test
French biotech Pharnext has seen the value of its shares collapse after it revealed that its lead drug, a treatment for Charcot-Marie-Tooth (CMT) disease, failed to make the grade in a phase 3 trial.
Pharmaceutical Technology18d
CKD-510 by Novartis for Charcot-Marie-Tooth Disease: Likelihood of Approval
CKD-510 is under development for the treatment of Charcot-Marie-Tooth disease and atrial fibrillation. It is administered through oral route.The drug candidate is a new chemical entity targeting ...
PBS1mon
Jean-Martin Charcot
Jean-Martin Charcot was born in Paris, France, late in 1825. Although he was a nineteenth century scientist, his influence carried on into the next century, especially in the work of some of his ...
Medscape8d
Neuropathic Arthropathy of the Shoulder (Charcot Shoulder)
Neuropathic osteoarthropathy, otherwise known as Charcot neuroarthropathy, is a chronic, degenerative arthropathy and is associated with decreased sensory innervation. Numerous causes of this ...